Combining ultrasmall gadolinium-based nanoparticles with photon irradiation overcomes radioresistance of head and neck squamous cell carcinoma

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 1, 2015, Pages 247-257

  Miladi, Imen ^a   Aloy, Marie Thérèse ^a   Armandy, Emma ^a   Mowat, Pierre ^a   Kryza, David ^a,b   Magné, Nicolas ^a   Tillement, Olivier ^a   Lux, François ^a   Billotey, Claire ^a,b   Janier, Marc ^a,b   Rodriguez Lafrasse, Claire ^a,c  

^a UNIVERSITÉ LYON 1   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Gadolinium nanoparticles; Head and neck squamous cell carcinoma (HNSCC); Radioresistance; Radiosensitization; Radiotherapy

Indexed keywords

CELL CULTURE; CELL DEATH; CELL PROLIFERATION; GADOLINIUM; IRRADIATION; PHOTONS; RADIOTHERAPY; THERANOSTICS; TUMORS;

DNA DOUBLE STRAND BREAKS; GADOLINIUM NANOPARTICLES; HEAD-AND-NECK SQUAMOUS CELL CARCINOMA; PHOTON IRRADIATION; RADIATION RESISTANCE; RADIO-SENSITIZATION; RADIORESISTANCE; THERANOSTIC AGENTS;

NANOPARTICLES;

GADOLINIUM BASED NANOPARTICLE; RADIOSENSITIZING AGENT; UNCLASSIFIED DRUG; CASPASE 2; GADOLINIUM; HISTONE; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER CELL LINE; CANCER INHIBITION; CANCER STEM CELL; CELL CYCLE M PHASE; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIGHT; MOUSE; NONHUMAN; RADIOSENSITIVITY; ANIMAL; CARCINOMA, SQUAMOUS CELL; CHEMISTRY; CONFOCAL MICROSCOPY; DNA DAMAGE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HEAD AND NECK NEOPLASMS; METABOLISM; NANOMEDICINE; NUDE MOUSE; PATHOLOGY; RADIOTHERAPY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CASPASE 2; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA DAMAGE; FEMALE; FLOW CYTOMETRY; GADOLINIUM; HEAD AND NECK NEOPLASMS; HISTONES; HUMANS; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NANOMEDICINE; NANOPARTICLES; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY;

EID: 84919866006     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.06.013     Document Type: Article

References (46)

1. Galvin J.M., De Neve W. Intensity modulating and other radiation therapy devices for dose painting. J Clin Oncol 2007, 25:924-930.
2. Pottier A., Borghi E., Levy L. New use of metals as nanosized radioenhancers. Anticancer Res 2014, 34:443-453.
3. Mc Carthy J.R., Weissleder R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 2008, 60:1241-1251.
4. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Itty Ipe B., et al. Renal clearance of quantum dots. Nat Biotechnol 2007, 25:1165-1169.
5. Hainfeld J.F., Dilmanian F.A., Slatkin D.N., Smilowitz H.M. Radiotherapy enhancement with gold nanoparticles. J Pharm Pharmacol 2008, 60:977-985.
6. Hainfeld J.F., Slatkin D.N., Smilowitz H.M. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 2004, 49:N309-N315.
7. Hainfeld J.F., Dilmanian F.A., Zhong Z., Slatkin D.N., Kalef-Ezra J.A., Smilowitz H.M. Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma. Phys Med Biol 2010, 55:3045-3059.
8. Butterworth K.T., Coulter J.A., Jain S., Forker J., Mcmahon S.J., Schettino G., et al. Evaluation of cytotoxicity and radiation enhancement using 1.9nm gold particles: potential application for cancer therapy. Nanotechnology 2010, 21:295101.
9. Rahman W.N., Bishara N., Ackerly T., He C.F., Jackson P., Wong C., et al. Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. Nanomedicine: NBM 2009, 5:136-142.
10. Hebert E.M., Bebouttière P.J., Lepage M., Sanche L., Hunting D.J. Preferential tumour accumulation of gold nanoparticles, visualized by magnetic resonance imaging: radiosensitization studies in vivo and in vitro. Int J Radiat Biol 2010, 86:692-700.
11. Bridot J.L., Faure A.C., Laurent S., Riviere C., Billotey C., Hiba B., et al. Hybrid gadolinium oxide nanoparticles: multinodal contrast agents for in vivo imaging. J Am Chem Soc 2007, 129:5076-5084.
12. Lux F., Mignot A., Mowat P., Louis C., Dufort S., Bernhard C., et al. Ultrasmall rigid particles as multimodal probes for medical applications. Angew Chem Int Ed Engl 2011, 50:12299-12303.
13. Bridot J.L., Dayde D., Riviere C., Mandon C., Billotey C., Lerondel S., et al. Hybrid gadolinium oxide nanoparticles combining imaging and therapy. J Mater Chem 2009, 19:2328-2335.
14. Kryza D., Taleb J., Janier M., Marmuse L., Miladi I., Bonazza P., et al. Biodistribution study of nanometric hybrid gadolinium oxide particles as a multimodal SPECT/MR/optical imaging and theragnostic agent. Bioconjug Chem 2011, 22:1145-1152.
15. Miladi I., Le Duc G., Kryza D., Berniard A., Mowat P., Roux S., et al. Biodistribution of ultra-small gadolinium-based nanoparticles as theranostic agent: application to brain tumors. J Biomater Appl 2013, 28:385-394.
16. Le Duc G., Miladi I., Alric C., Mowat P., Bräuer-Krisch E., Bouchet A., et al. Towards an image-guided microbeam radiation therapy using gadolinium-based nanoparticles. ACS Nano 2011, 5:9566-9574.
17. Mowat P., Mignot A., Rima W., Lux F., Tillement O., Roulin C., et al. In vitro radiosensitizing effects of ultrasmall gadolinium based nanoparticles on tumour cells. J Nanosci Nanotechnol 2011, 11:7833-7839.
18. Rima W., Sancey L., Aloy M.T., Armandy E., Alcantara G.B., Epicier T., et al. Internalization pathways into cancer cells of gadolinium-based radiosensitizing nanoparticles. Biomaterials 2013, 34:181-195.
19. Weichselbaum R.R., Dahlberg W., Beckett M., Karrison T., Miller D., Clark J., et al. Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head-and-neck-cancer patients. Proc Natl Acad Sci U S A 1986, 83:2684-2688.
20. Alphonse G., Bionda C., Aloy M.T., Ardail D., Rousson R., Rodriguez-Lafrasse C. Overcoming resistance to gamma-rays in squamous carcinoma cells by poly-drug elevation of ceramide levels. Oncogene 2004, 23:2703-2715.
21. Bertrand G., Maalouf M., Boivin A., Battiston-Montagne P., Beuve M., Levy A., et al. Targeting head and neck cancer stem cells to overcome resistance to photon and carbon ion radiation. Stem Cell Rev 2014, 10:114-126.
22. Gioanni J., Fischel J.L., Lambert J.C., Demard F., Mazeau C., Zanghellini E., et al. Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. Eur J Cancer Clin Oncol 1988, 24:1445-1455.
23. Hanot M., Boivin A., Malesys C., Beuve M., Colliaux A., Foray N., et al. Glutathione depletion and carbon ion radiation potentiates clustered DNA lesions, cell death and prevents chromosomal changes in cancer cells progeny. Plos One 2012, 7:e44367.
24. Steel G., Peckham M.G. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 1979, 5:85-93.
25. Kano Y., Ohnuma T., Okano T., Holland J.F. Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture. Cancer Res 1988, 48:351-356.
26. Rodriguez-Lafrasse C., Alphonse G., Broquet P., Aloy M.T., Louisot P., Rousson R. Temporal relationships between ceramide production, caspase activation and mitochondrial dysfunction in cell lines with varying sensitivity to anti-fas-induced apoptosis. Biochem J 2001, 357:407-416.
27. Bionda C., Athias A., Poncet D., Alphonse G., Guezguez A., Gambert P., et al. Differential regulation of cell death in head and neck cell carcinoma through alteration of cholesterol levels in lipid rafts microdomains. Biochem Pharmacol 2008, 75:761-772.
28. Vakifahmetoglu H., Olsson M., Zhivotovsky B. Death through a tragedy: mitotic catastrophe. Cell Death Differ 2008, 15:1153-1162.
29. Eriksson D., Stigbrand T. Radiation-induced cell death mechanisms. Tumour Biol 2010, 31:362-372.
30. Firat E., Gaedicke S., Tsurumi C., Esser N., Weyerbrock A., Niedermann G. Delayed cell death associated with mitotic catastrophe in γ-irradiated stem-like glioma cells. Radiat Oncol 2011, 6:71.
31. Maalouf M., Alphonse G., Colliaux A., Beuve M., Trajkovic-Bodennec S., Battiston-Montagne P., et al. Different mechanisms of cell death in radiosensitive and radioresistant p53 mutated head and neck squamous carcinoma cell lines exposed to carbon ions and x-rays. Int J Radiat Oncol Biol Phys 2009, 74:200-209.
32. Morgan M.A., Parsels L.A., Zhao L., Parsels J.D., Davis M.A., Hassan M.C., et al. Mechanism of radiosensitization by the Chk 1/2 inhibitor AZD 7762 involves abrogation of the G2 checkpoint and inhibition of homologous recombinational DNA repair. Cancer Res 2010, 70:4972-4981.
33. Townley H.E., Rapa E., Wakefield G., Dobson P.J. Nanoparticle augmented radiation treatment decreases cancer cell proliferation. Nanomedicine: NBM 2012, 8:526-535.
34. Boivin A., Hanot M., Malesys C., Maalouf M., Rousson R., Rodriguez-Lafrasse C., et al. Transient alteration of cellular redox buffering before irradiation triggers apoptosis in head and neck carcinoma stem and non-stem cells. Plos One 2011, 6:e1455.
35. Hadchity E., Aloy M.T., Paulin C., Armandy E., Watkin E., Rousson R., et al. Heat shock protein 27 as a new therapeutic target for radiation sensitization of head and neck squamous cell carcinoma. Mol Ther 2009, 17:1387-1394.
36. Aloy M.T., Hadchity E., Bionda C., Diaz-Latoud C., Claude L., Rousson R., et al. Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells. Int J Radiat Oncol Biol Phys 2008, 70:543-553.
37. Brunner T.B., Kunz-Schughart L.A., Grosse-Gehling P., Baumann M. Cancer stem cells as a predictive factor in radiotherapy. Semin Radiat Oncol 2012, 22:151-174.
38. Chang M.Y., Shiau A.L., Chen Y.H., Chang C.J., Chen H.H.W., Wu C.L. Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice. Cancer Sci 2008, 99:1479-1484.
39. Hainfeld J.F., Smilowitz H.M., O'Connor M.J., Dilmanian F.A., Slatkin D.N. Gold nanoparticle imaging and radiotherapy of brain tumors in mice. Nanomedicine (Lond) 2013, 10:1601-1609.
40. Maggiorella L., Barouch G., Devaux C., Pottier A., Deutsch E., Bourhis J., et al. Nanoscale radiotherapy with hafnium oxide nanoparticles. Future Oncol 2012, 8:1167-1181.
41. Morlieras J., Dufort S., Sancey L., Truillet C., Mignot A., Rossetti F., et al. Functionalization of small rigid platforms with cyclic RGD peptides for targeting tumors overexpressing αvβ3-integrins. Bioconjug Chem 2013, 24:1584-1597.
42. Morlieras J., Chezal J.M., Miot-Noirault E., Vidal A., Besse S., Kryza D., et al. In vivo evidence of the targeting of cartilaginous tissue by pyridinium functionalized nanoparticles. Chem Commun (Camb) 2013, 49:3046-3048.
43. Morlieras J., Chezal J.M., Miot-Noirault E., Roux A., Heinrich-Balard L., Cohen R., et al. Development of gadolinium based nanoparticles having an affinity towards melanin. Nanoscale 2013, 5:1603-1615.
44. Fizet J., Riviere C., Bridot J.L., Charvet N., Louis C., Billotey C., et al. Multi luminescent hybrid gadolinium oxide nanoparticles as potential cell labeling. J Nanosci Nanotechnol 2009, 9:5717-5725.
45. Kim T.J., Chae K.S., Chang Y., Lee G.H. Gadolinium oxide nanoparticles as potential multimodal imaging and therapeutic agents. Curr Top Med Chem 2013, 13:422-433.
46. Mignot A., Truillet C., Lux F., Sancey L., Louis C., Denat F., et al. A top-down synthesis route to ultrasmall multifunctional Gd-based silica nanoparticles for theranostic applications. Chemistry 2013, 19:6122-6136.